(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SIDEVIT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SIDEVIT

ST13

US500000079402594

Classe

5

Pedido

79402594

Registro

7846584

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

35

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

30/04/2024

Data de registro

01/07/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/07/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

IT

Examinador

LAVACHE, LINDA M

Localização atual

Historical data usage

Titulares e representantes

Titulares

PHARMANUTRA S.P.A.

Representantes

Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals for the treatment and prevention of gynecologicalurologicalgastroenterologicalimmunologiccardio-vasculardermatologicaloral hygiene and osteo-articular diseases and conditions; medical preparationsmedicinal preparations for treatment and prevention of gynecologicalurologicalgastroenterologicalimmunologiccardio-vasculardermatologicaloral hygiene and osteo-articular diseases and conditions; veterinary preparations for the treatment and prevention of vitamin deficiencyurologicalgastroenterologicalimmunologiccardio-vasculardermatologicalosteo-articular diseases and conditions; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical and veterinary use; food for babies; dietary supplements for human beings and animals ; dietary supplements and dietetic preparations in the nature of foodstuffs adapted for medical purposes; sanitary preparations and articlessanitary sterilizing preparationsdisinfectants for sanitary purposes; nutritional supplements for medical use; dietetic foods adapted for medical use; dietetic beverages adapted for medical use; dietary supplements for humansnot for medical use; vitamin supplements; nutritional supplements; medicated food supplements; protein dietary supplements; vitamin and mineral supplements; dietary supplements for infants; protein powder dietary supplements; whey protein dietary supplements; food supplements in liquid form; probiotic supplements; anti-oxidant nutritional supplements; prebiotic supplements; mineral dietary supplements; dietary supplements in powder form; health food supplements for persons with special dietary requirements; pastilles for pharmaceutical purposescough pastilles for medical use; syrups for pharmaceutical purposes for the treatment of cold and flu; dietetic substances adapted for medical usedietary supplements; pharmaceuticals and natural remedy preparations for the treatment and prevention of gynecologicalurologicalgastroenterologicalimmunologiccardio-vasculardermatologicaloral hygiene and osteo-articular diseases and conditions; pharmaceutical preparations and substances for the treatment and prevention of gynecologicalurologicalgastroenterologicalimmunologiccardio-vasculardermatologicaloral hygiene and osteo-articular diseases and conditions; nutraceutical preparations for therapeutic or medical purposes for the treatment and prevention of gynecologicalurologicalgastroenterologicalimmunologiccardio-vasculardermatologicaloral hygiene and osteo-articular diseases and conditions; nutraceuticals for use as a dietary supplement * ; none of the aforementioned goods are intended for veterinary use *

Publicações

Histórico de despachos e eventos da marca no USPTO.

35 publicações encontradas

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

24/02/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

19/02/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/02/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/02/2026

FIMP

FINAL DISPOSITION PROCESSED

03/02/2026

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

03/02/2026

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

03/02/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

21/01/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

21/01/2026

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

05/12/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/10/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/05/2025

PUBO

PUBLISHED FOR OPPOSITION

13/05/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/04/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

14/04/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/04/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

14/04/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/04/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/04/2025

RFNT

REFUSAL PROCESSED BY IB

29/12/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/12/2024

RFRR

REFUSAL PROCESSED BY MPU

06/12/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/11/2024

CNRT

NON-FINAL ACTION WRITTEN

20/11/2024

DOCK

ASSIGNED TO EXAMINER

14/11/2024

MAFR

APPLICATION FILING RECEIPT MAILED

26/08/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/08/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

22/08/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SIDEVIT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.